Recent advances predict a bright future for nebulizers
- 9 January 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 29 (2) , 123-132
Abstract
Purpose of review: With the improvement in device technology and delivery methods of inhaled medications, along with development of novel compounds and recognition of the importance of personalized approach in the management of chronic airway diseases, nebulizers have not only maintained their place in the treatment hierarchy of airway disease but have also proven a vital platform for the development of new classes of drugs. Recent findings: This short review explores recent advances in nebulized drug delivery in chronic obstructive pulmonary disease and other chronic airway diseases, emphasizing the progress in nebulizer technology, physiologic advantages of nebulized drug delivery and the high versatility of currently available and developing nebulizer-delivered pharmacotherapies. Summary: Versatility and efficiency of nebulizers allows for a broad spectrum of existing and novel therapies to be clinically studied, facilitating the progress in phenotype-targeted pharmacotherapies in the management of chronic airway diseasesKeywords
This publication has 60 references indexed in Scilit:
- Jet, Ultrasonic, and Mesh Nebulizers: An Evaluation of Nebulizers for Better Clinical OutcomesEurasian Journal of Pulmonology, 2014
- Inhaler technique and patient's preference for dry powder inhaler devicesExpert Opinion on Drug Delivery, 2013
- Overcoming the Undesirable Properties of dry-powder Inhalers With Novel Engineered Mannitol ParticlesTherapeutic Delivery, 2013
- Comparison of Dry Powder versus Nebulized Beta-Agonist in Patients with COPD Who Have Suboptimal Peak Inspiratory Flow RateJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2013
- Have inadequate delivery systems hampered the clinical success of inhaled disodium cromoglycate? Time for reconsiderationExpert Opinion on Drug Delivery, 2010
- Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPDAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled TrialClinical Infectious Diseases, 2008
- The role of nebulised budesonide in the treatment of exacerbations of COPDEuropean Respiratory Journal, 2007
- Plastic bronchitis: new insights and a classification schemePaediatric Respiratory Reviews, 2005
- Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant NacystelynAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004